1.
Post-market Reevaluation of the Effectiveness and Safety of Double-Coptis-Powder Injection in the Treatment of Children's Acute upper Respiratory Infection
双黄连粉针剂治疗儿童急性上呼吸道感染的上市后再评价研究
2.
Discussion on Drug Reevaluation by Analyzing Adverse Drug Reaction of Traditional Chinese Medicine Injection
从中药注射剂不良反应看中药的上市后再评价问题
3.
Re-evaluation of Post-marketing Safety for LevamisoleⅢ:Risk Prevention Countermeasures;
左旋咪唑上市后安全性再评价Ⅲ：风险预防对策
4.
Study on the Supervision and Re-evaluation Approach to Post-market Medical Products of FDA;
FDA对医药产品上市后监测与再评价的方法及其启示
5.
Evidence-Based Safety Reassessment of Post Marketed Drug - Importance of Recall of Refecoxib;
应重视上市后药物安全性的循证医学再评价——罗非昔布召回的意义
6.
Safety re-evaluation on nimesulide in treatment of rheumatoid arthritis and osteoarthritis after postmarketing
尼美舒利治疗类风湿关节炎和骨关节炎上市后安全性再评价
7.
Study on Assessing Value of Public Company after Share Trading Reform;
股权分置改革后上市公司价值评估研究
8.
The insights on post-marketing evaluation in China;
关于我国药品上市后评价技术工作的思考
9.
Post-prject Evaluation of Line M8 Changing Project of Shanghai Mass Transmit
上海市轨道交通M8线牵降变工程项目后评价
10.
Comparison of Quality Evaluation System of Post-marketing Drug in China,USA and Japan
中日美药品上市后质量评价体系的比较
11.
Detective and Evaluation of Safety Signals to the Post-marketing Chinese Herbal Drugs
中成药上市后“安全性信号”的识别与评价
12.
Postmarketing Review of Astemizole Safety Assessment in Cardiovascular System
阿司咪唑上市后心脏毒性安全性评价文献调研
13.
Post-marketing Reevaluation and Risk Control Measures of Acarbose
阿卡波糖的上市后评价与风险控制研究
14.
Systematic Review of Prognosis Factors after Secondary Surgery in Recurrent Ovarian Cancer;
复发卵巢上皮癌再次手术患者预后因素的系统评价
15.
An Introduction to Methods for Economic Evaluation of Marketed Medicines I: Setting up an Economic Framework and Reviewing Existing Evidence;
上市后药物经济学评价方法(Ⅰ)——建立经济学评价框架,评价经济学证据(英文)
16.
This person sells "borrowed" stock, in hope of replacing it later with stock bought on the open market at a lower price.
他出售“借来的”股票，想在股票价格下跌之后再在市场上买回来。
17.
4 Reassessing the environment quality after the remedial measure is taken.
(4)采取措施后，再评价环境质量。
18.
The Assessment of the Myocardial Microvascular Perfusion after Coronary Revascularization by Corrected TIMI Frame Count;
校正TIMI帧数法对冠脉再通后心肌再灌注的评价